As of August 2026, 35 paid clinical trials are recruiting for Blood cancer in Hackensack, New Jersey. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Hackensack, NJ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hackensack University Medical Center | Heart Failure, Advanced Solid Tumor, Neuroblastoma | 122 |
| John Theurer Cancer Center at Hackensack University Medical Center | Acute Myeloid Leukemia, Leukemia, Myeloid, Acute, Breast Cancer | 44 |
| John Theurer Cancer Center | Melanoma, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer | 13 |
| Hackensack Meridian Health | Atrial Fibrillation, Breast Cancer, Cardiogenic Shock | 11 |
| John Theurer Cancer Center at Hackensack UMC | Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Lung Cancer | 7 |
| John Theurer Cancer Center Hackensack University Medical Center | Advanced Solid Tumor, Advanced Solid Tumors, Chronic Lymphocytic Leukemia | 6 |
| Northeast Regional Epilepsy Group | Epilepsy, Focal Epilepsy, Focal Onset Seizures | 6 |
| Hackensack Medical Center | Myelodysplastic Syndromes, Acute Myeloid Leukemia, Alzheimer Disease | 5 |
| Hackensack Meridian Health (Data collection only) | Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma, High Grade B Cell Lymphoma | 4 |
| Hackensack Meridian Health - Hackensack University Medical Center | Plasma Cell Myeloma Refractory, Hemophilia, Glycogen Storage Disease Type II | 4 |
| John Theurer Cancer Center, Hackensack University Medical Center | Blood Protein Disorders, Essential Thrombocythemia, Gene Therapy | 3 |
| GSK Investigational Site | HIV Infections, Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 2 |
| HMH Hackensack University Medical Center | Clostridoides Difficile Associated Disease, Stroke, Acute | 2 |
| Hackensack Univeristy Medical Center | Pre-Term, Premature, Respiratory Distress Syndrome in Premature Infant | 2 |
| Hackensack University Medical Center - John Theurer Cancer Center | Endometrial Cancer, Non-squamous EGFR Wt NSCLC, Ovarian Cancer | 2 |
| John Theurer Cancer Center-Hackensack | Locally Advanced Extrapulmonary Neuroendocrine Carcinoma, Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung, Locally Advanced Merkel Cell Carcinoma | 2 |
| Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center | Low-grade Glioma, BRAF V600 Mutation, High-Grade Glioma (HGG) | 2 |
| Joseph M. Sanzari Children's Hospital | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 2 |
| NEREG | Focal Epilepsy | 2 |
| Praxis Research Site | Epilepsy, Tonic-Clonic, Focal Onset Seizure, Focal Seizure | 2 |
| Amanda Khoudary | Lung Cancer | 1 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Context Investigational Site | Cholangiocarcinoma Advanced, Cholangiocarcinoma Non-resectable, Colorectal Cancer | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Drug-Drug Interaction (DDI) | 1 |
| HMH David Jurist Research Building | Clostridoides Difficile Associated Disease | 1 |
Recruiting trials in Hackensack grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 300 recruiting clinical trials in Hackensack, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Hackensack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Hackensack include Acute Myeloid Leukemia (9), Breast Cancer (9), Advanced Solid Tumor (8), Ovarian Cancer (8), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hackensack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Hackensack include Hackensack University Medical Center, John Theurer Cancer Center at Hackensack University Medical Center, John Theurer Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Hackensack are Cancer & tumors (168), Cardiovascular (13), Neurology & pain (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.